| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/08/1998 | EP0834313A1 Therapeutic treatment for central nervous system diseases associated with HIV infection |
| 04/08/1998 | EP0833933A1 A method for producing influenza hemagglutinin multivalent vaccines |
| 04/08/1998 | EP0833929A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 04/08/1998 | EP0833925A1 Diagnostic test for equine arteritis virus mediated disease |
| 04/08/1998 | EP0833924A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 04/08/1998 | EP0833923A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 04/08/1998 | EP0833921A1 ADHERENCE GENE FROM $i(HELICOBACTER PYLORI) AND POLYPEPTIDE CODED THEREBY |
| 04/08/1998 | EP0833920A2 Transferrin receptor genes |
| 04/08/1998 | EP0833919A1 Type f botulinum toxin and use thereof |
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833903A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833826A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 04/08/1998 | EP0833825A1 6-carboxamido dihydropyran derivatives |
| 04/08/1998 | EP0833824A2 Small molecule inhibition of rna/ligand binding |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833668A1 Inhibition of hepatitis b replication |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833662A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 04/08/1998 | EP0833661A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/08/1998 | EP0833660A1 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 04/08/1998 | EP0833657A1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |
| 04/08/1998 | EP0833645A1 Antiviral agents |
| 04/08/1998 | EP0833635A1 Novel use for pyrrole derivatives |
| 04/08/1998 | EP0833631A1 Biflavanoids and derivatives thereof as antiviral agents |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0711170B1 T-lymphocyte-containing pharmaceutical composition for treating infections |
| 04/08/1998 | EP0623021B1 4''-deoxyerythromycin derivatives |
| 04/08/1998 | EP0558630B1 Retroviral protease inhibitors |
| 04/08/1998 | EP0539516B1 Asphodelus composition for increasing white blood cell count |
| 04/08/1998 | CN1178220A Process for producing cefazolin |
| 04/08/1998 | CN1178121A Injection for AIDs and preparation thereof |
| 04/08/1998 | CN1037967C Novel intermediate and its use of preparation of acid |
| 04/07/1998 | US5736574 Comprising a hydrolipid and at least one glyceryl monoalkyl ether |
| 04/07/1998 | US5736563 Transcutaneous in vivo activation of photosensitive agents in blood |
| 04/07/1998 | US5736549 Hypoxanthine and guanine compounds |
| 04/07/1998 | US5736533 Inhibiting colonization of streptococcus pneumoniae, hemophilus influenza or parainfluenza, burkholderia (pseudomonas) cepacia by administering binding inhibiting oligosaccharide |
| 04/07/1998 | US5736525 Used for treatemnt of acquired immuno deficiency syndrome with anti-aids drugs selected from 3'-azido-3'-deoxythymidine(azt), dideoxyinosine(ddi), or dideoxycytidine(ddc) |
| 04/07/1998 | US5736524 Polynucleotide tuberculosis vaccine |
| 04/07/1998 | US5736391 HIV gp41 mutants |
| 04/07/1998 | US5736361 Production of gonorrheal PI proteins |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736319 Analyzing for absence of glycoproteins x or i in pseudorabies virus antigen-containing serum of animals (i.e. swine) to distinguish between vaccination and virulent infections |
| 04/07/1998 | US5736317 Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium |
| 04/07/1998 | US5736294 Genetic engineering |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736133 Method and composition for the treatment of a individual infected with an immunodeficiency virus |
| 04/07/1998 | CA1339808C Glycopeptide antibiotics |
| 04/02/1998 | WO1998013376A1 Inhibitors of pla¿2? |
| 04/02/1998 | WO1998013373A1 Erythromycin a derivatives |
| 04/02/1998 | WO1998013352A1 2-deoxy-2-amino(or 2-methylamino)-d-glucose salts comprising n-arachidonacetic acid and showing anti-microbial activity |
| 04/02/1998 | WO1998013061A1 Inhibition of 26s and 20s proteasome by indanones |
| 04/02/1998 | WO1998013055A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 04/02/1998 | WO1998013042A1 Antimycotic gel with high active substance release |
| 04/02/1998 | DE19640364A1 Topische Mittel zur Prophylaxe oder Behandlung bakterieller Hautinfektionen Topical agents for the prophylaxis or treatment of bacterial skin infections |
| 04/02/1998 | DE19639816A1 Antimykotische Mittel mit hoher Wirkstofffreisetzung Antifungal agent with high drug release |
| 04/02/1998 | CA2814748A1 O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates |
| 04/02/1998 | CA2266746A1 Inhibitors of pla2 |
| 04/02/1998 | CA2263134A1 Cytotoxic peptides |
| 04/01/1998 | EP0832980A1 Recombinant therapies for infection and hyperproliferative disorders |
| 04/01/1998 | EP0832978A2 Novel 3-dehydroquinate synthase |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832887A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug |
| 04/01/1998 | EP0832879A1 Process for preparing intermediates for thrombin inhibitors |
| 04/01/1998 | EP0832846A2 Complexes of polymer and hydrogen peroxide |
| 04/01/1998 | EP0832265A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0832260A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
| 04/01/1998 | EP0832253A2 Nucleic acid respiratory syncytial virus vaccines |
| 04/01/1998 | EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 04/01/1998 | EP0832242A1 Neutralizing conformational epitopes of chicken anemia virus |
| 04/01/1998 | EP0832241A1 Mutants of streptococcal toxin a and methods of use |
| 04/01/1998 | EP0832238A1 Streptococcal heat shock proteins members of the hsp70 family |
| 04/01/1998 | EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
| 04/01/1998 | EP0832198A1 Oxygen activatable formulations for disinfection or sterilization |
| 04/01/1998 | EP0832197A1 Recombinant fowlpox viruses and uses thereof |
| 04/01/1998 | EP0832194A1 Bile duct progenitor cells and methods of use |
| 04/01/1998 | EP0832120A2 Anti-fungal d-amino acid histatin-based peptides |
| 04/01/1998 | EP0832119A2 Anti-fungal and anti-bacterial histatin-based peptides |
| 04/01/1998 | EP0832099A1 Reversible cysteine protease inhibitors |
| 04/01/1998 | EP0832094A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 04/01/1998 | EP0832084A1 Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0832059A1 Method for the preparation of an n-(2-bromoalkyl)-amide derivative |
| 04/01/1998 | EP0831937A1 Immunological combination compositions and methods |
| 04/01/1998 | EP0831921A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0831916A1 Treatment of cholera |
| 04/01/1998 | EP0831915A1 Treatment of cholera |
| 04/01/1998 | EP0831914A1 Treatment of traveller's diarrhea |
| 04/01/1998 | EP0831913A1 Treatment of traveller's diarrhea |
| 04/01/1998 | EP0831912A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 04/01/1998 | EP0831901A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 04/01/1998 | EP0831900A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
| 04/01/1998 | EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
| 04/01/1998 | EP0831898A1 Modified meningococcal polysaccharide conjugate vaccines |
| 04/01/1998 | EP0831897A1 In ovo vaccination against coccidiosis |
| 04/01/1998 | EP0831894A1 Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them |